Revvity signals beyond the news: 20 signals from 3 sources
The latest Revvity signal on this page is from Oct 27, 2026 (Patents): "REVVITY HEALTH SCIENCES, INC.'s patent output is steady: 10 grants in the past year, 1 in the past 30 days." The busiest sources: Glassdoor (14), Reddit (3) and Patents (3).
PublicBiotechnology Research1,001 to 5,000 employeesrevvity.comLinkedIn
Get Revvity's live signals in Claude or ChatGPT, or by API
What changed at Revvity this week? Use Autobound signals for revvity.com.- Signals
- 20
- Sources
- 3
- Last 90 days
- 16
- Latest
- Oct 27, 2026
Source: Autobound Signal API · 23 signals tracked for Revvity · updated
Other signals · latest 10
Latest Revvity signals by source
20 signals for Revvity across 3 sources.
Patents · Patent pace
REVVITY HEALTH SCIENCES, INC.'s patent output is steady: 10 grants in the past year, 1 in the past 30 days.
Over the past year REVVITY HEALTH SCIENCES, INC. received 10 US patent grants; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 10
- Grants, 90 days
- 1
- Grants, 30 days
- 1
- USPTO assignee
- Revvity Health Sciences, Inc.
Reddit · Customer feedback
Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate...
Post: "Dear lab supply companies - please give me the free software to the $20k instrument I already own"
- Subreddit
- r/labrats
- Upvotes
- 839
- Comments
- 53
- Sentiment
- Negative
Glassdoor · Acquisition integration issues
Company integration challenges create uncertainty and impact small businesses
A manager notes that constant changes from integrating newly acquired companies create uncertainty and effectively sideline smaller businesses within the organization, impacting their development.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 7
- Review window
- Sep 11, 2026 to Oct 9, 2026
Glassdoor · Compensation dissatisfaction
Revvity employees report pay below industry standards and raise concerns
Two reviewers mention low pay compared to industry standards in California and frustration with salary progression, with one noting that pay bumps are needed to attract and retain staff.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 7
- Review window
- Sep 11, 2026 to Oct 9, 2026
Glassdoor · Growth opportunities
Employees cite unclear promotion paths and limited career development
Three employees report a lack of clarity regarding promotion criteria and limited opportunities for career progression and skill development within the company.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 7
- Review window
- Sep 11, 2026 to Oct 9, 2026
Glassdoor · Talent retention concerns
High turnover and minimal staffing lead to overworked employees
One technologist states there is high turnover and employees are overworked due to minimal staffing, hindering the ability to secure new hires and retain current staff.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 7
- Review window
- Sep 11, 2026 to Oct 9, 2026
Patents · Patent counsel
REVVITY HEALTH SCIENCES, INC. uses Seed Intellectual Property Law Group LLP as outside IP counsel.
Seed Intellectual Property Law Group LLP is the attorney of record on REVVITY HEALTH SCIENCES, INC.'s recent US patent work, including a grant in 2026-09.
- Law firm
- Seed Intellectual Property Law Group LLP
- Law firm domain
- seedip.com
- Matter date
- Sep 29, 2026
Patents · Patent grant
Revvity Health Sciences was granted a patent for multiplexed PCR automation.
In September 2026 Revvity Health Sciences patented a compact system for running multiplexed PCR tests in research and clinical laboratories.
- Patent title
- Multiplexed polymerase chain reaction in micropipette format
- Grant date
- Sep 29, 2026
- Inventors
- Andrew Brodsky
Reddit · Buying intent
A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes.
Post: "CRISPRa arrayed screen"
- Subreddit
- r/labrats
- Upvotes
- 1
- Comments
- 2
- Sentiment
- Neutral
Reddit · Product change
Revvity has discontinued the free version of ChemSketch software following its recent acquisition of the original developer, ACD/Labs.
Post: "No more free ChemSketch"
- Subreddit
- r/Chempros
- Upvotes
- 90
- Comments
- 40
- Sentiment
- Negative
Showing 10 of 20 signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Revvity with the Signal API
One POST /v1/companies/enrich call with revvity.com returns Revvity signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "revvity.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Revvity other signals
What signals does Autobound track for Revvity besides news and filings?
What are people saying about Revvity online?
What do employees say about working at Revvity?
Has Revvity been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .